Clinical trial
Study In Patients With Depression Not Responding to Selective Serotonin…
NCT00296517 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00296517 |
|---|---|
| Title | Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors |
| Official title | Clinical Evaluation of 323U66 SR in Patients With Depression - Placebo-controlled, Double-blind, Comparative Study in Patients With Depression Who Did Not Respond Sufficiently to Selective Serotonin Re-uptake Inhibitors |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | 323U66 (Bupropion Hydrochloride Sustained Release), Placebo |
| Enrollment | 325 |
| Start date | Jan 19, 2006 |
| Primary completion | Mar 28, 2008 |
| Completion | Mar 28, 2008 |
| First posted | Feb 27, 2006 |
| Last update posted | Dec 4, 2019 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: